Our expertise in medical research is targeted toward creating new vaccines in areas of unmet need as well as adapting existing vaccines for more effective delivery in low-income nations. Numerous barriers hamper access to life-saving vaccines for millions of people living in the developing world. First, the lack of commercial return has limited private sector investment in new solutions for diseas
es that predominately affect low-income countries. Secondly, many licensed vaccines available in the market today were developed and manufactured with industrialized world citizens in mind. We aim to create a novel immunization platform by employing modern technologies focusing on: Thermostability, Ease-of-administration, Reduced Footprint and Affordability.